L606 is a liposomal formulation for treatment of pulmonary arterial hypertension. The product features local delivery, a sustained release profile, mitigated irritation and the potential of reducing daily dosing frequency. As an inhalation product, the high concentration of formulation with a high output nebulizer shortens the inhalation time, increases device adherence/compliance and improves patients’ quality of life.